Drug Development Support for the Cancer Therapy Evaluation Program

Awarded Award Notice Posted

Solicitation number
75N91021R00043
Agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
Awarded
to Technical Resources International, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75N91022C00014 Federal contract award
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN13 Health R&D Services; Health Care Services; Experimental Development
Place of performance
Rockville, Maryland 20850, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Technical Resources International, Inc. was awarded a contract by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide drug development support for the Cancer Therapy Evaluation Program. The contract, valued at $112,550,864, was awarded on June 24, 2022 to support the agency's evaluation of new drugs and therapies for the treatment of cancer.

Notice text

Awarded contract 75N91022C00014 to Technical Resources International, Inc. for 112550864.00 on 2022-06-24.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Drug Development Support for the Cancer Therapy Evaluation Program This notice · Award Award Notice
Drug Development Support for the Cancer Therapy Evaluation Program Latest solicitation Solicitation
Drug Development Support for the Cancer Therapy Evaluation Program Pre-Solicitation
Drug Development Support for the Cancer Therapy Evaluation Program Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity